EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Nynomic AG (M7U) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Nynomic AG €13.51, price €23.50, upside -42.5%, quality 50 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Technology · DE · ISIN DE000A0MSN11

NA Some data Sep 23, 2026

Nynomic AG

M7U · XETRA

Weakest SetupStrongly overvalued and low quality.

!Fair value €13.51 · Strongly overvalued (−43%)
!Quality 50/100
!Weak Growth (revenue 5y +3.3 %/yr)
!Loss-making · -0.8% net margin (TTM)
✓Low debt · generates free cash flow
!Trails peers (4/13)
!Narrow moat 29/100
!Evidence only medium, so the estimate is less certain
!Weak on dividend: 14 out of 100
Watch Nynomic AG for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€54.40 €8.36 Fair Value €13.51 Jul 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range €8.36 – €54.40 · fair‑value band €9.79 – €17.47 · the €23.50 price screens above the €13.51 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Nynomic in your weekly email

Every Wednesday you see whether Nynomic is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nynomic AG, together with its subsidiaries, manufactures and sells products for permanent, non-contact, and non-destructive optical measurement technology.

Show more

Nynomic AG, together with its subsidiaries, manufactures and sells products for permanent, non-contact, and non-destructive optical measurement technology. The company also supplies customized system solutions in the areas of control engineering, sensor technology, and laboratory automation or spectrometry; components and systems for industrial optical spectroscopy, including UV-VIS-NIR and Raman diode array spectroscopy with associated software solutions; and develops and manufactures optical measurement systems for various applications. In addition, it provides spectrometers, light sources for UV, VIS, and NIR, as well as fibre optics or optical waveguides, accessories, and customer-specific products for OEM applications, as well as scientific market; optical measurement and control technology systems; process-integrated measurement technology solutions; and hardware and software systems for digital plant phenotyping and high-throughput screening fields. Further, the company develops, produces, and distributes infrared measurement technology; development and manufacture of test and calibration equipment for cameras and multi-sensor systems; micro-incandescent lamps, lenses, and special lamps; and special fibres for optical measurement technology. The company was formerly known as m-u-t AG and changed its name to Nynomic AG in August 2018. Nynomic AG was incorporated in 1995 and is headquartered in Wedel, Germany.

Stock analysis

Nynomic AG (M7U) currently trades at €23.50, while our model-based Fair Value estimate is €13.51, implying the stock looks roughly 73.9% overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €13.54 per share, and 0 of the 13 models we run sit above the €23.50 price.

Bear case: the Asset-Based group reads lowest at €9.83, and 13 of the 13 models stay below the price. Evidence for this calculation is medium.

Scenario range: €9.79 (bear) to €17.47 (bull), the price of €23.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 50/100 (solid quality), in the Technology sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Nynomic AG reported revenue of €92.6M in FY2025 versus €105M in FY2021, a compound −3.1%/yr. Reported net income was −€704K in FY2025.

Key figures

Market cap €154M · P/S ratio 1.12 · EPS (TTM) €−0.1100 · Dividend yield 0.7% · Net margin −0.8% · Return on equity −0.3% · Return on assets (EBIT) 7.2% · Operating margin 7.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 6% below its 52-week high and 181% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at −35% fair-value upside, at −43%, M7U screens richer than that median.

Fair Value models

Bear €9.79 Fair Value €13.51 Bull €17.47
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF €9.92 €12.68 €16.05 80
Growth DCF €9.96 €12.38 €15.16 78
Owner Earnings €7.40 €9.26 €11.53 76
All 13 models by family
DCF Models
FCF DCF €9.92 €12.68 €16.05 80
Owner Earnings €7.40 €9.26 €11.53 76
5Y Revenue Exit €9.77 €13.60 €18.38 71
5Y EBITDA Exit €10.88 €15.64 €21.06 73
10Y Revenue Exit €9.57 €12.71 €16.71 66
10Y EBITDA Exit €10.35 €13.91 €18.43 67
Dividend Discount
Gordon GGM €0.7500 €1.26 €1.63 66
DDM Multi-Stage €0.7500 €1.09 €1.35 65
Multiples
EV/EBITDA €12.97 €16.56 €20.16 67
EV/Revenue €10.13 €13.54 €16.95 54
Asset-Based
NCAV (Graham) €7.33 €9.83 €14.67 54
Growth DCF
Growth DCF €9.96 €12.38 €15.16 78
Rev-Margin DCF €9.77 €13.68 €18.09 71

Open the full fair value analysis →

Notify me when M7U reaches fair value

Put M7U on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 50/100

Of which business quality 51 · Market factors (momentum, volatility) 77

Profitability 21
Margins and returns on capital today
Quality Growth 16
Are margins and returns improving?
Cashflow 49
Earnings quality: real cash, not paper profit
Fin. Strength 84
Balance sheet, leverage, solvency risk
Investment 82
Disciplined investing over empire-building
Low Volatility 28
Calm price path (market factor)
Momentum 99
Price trend over the last 3–12 months (market factor)
52W Momentum 96
Distance to the 52-week high (market factor)
Net Issuance 62
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 31/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−9.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
Start year 2020 (pandemic). Over 10 years: +5.9% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
10.1% (2020) → −0.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+21.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +18.4% a year for the price.

M7U screens 74% overvalued. Compare with Keysight Technologies, Inc →

Compare Nynomic AG with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 160 stocks

Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 50 · Below median
Fair Value upside −45% · Below median
Profitability
Return on assets 1% · Below median
Net margin (TTM) −1% · Bottom 25%
Operating margin (TTM) 8% · Above median
Growth and dividend
Revenue growth −12% · Bottom 25%
Dividend yield (TTM) 0.7% · Below median
Balance sheet
Debt / equity 0.00× · Below median

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/B 1.92× · Cheaper than median
P/S (TTM) 1.98× · Cheaper than median
P/FCF 32.2× · Priciest 25%
EV/EBITDA 36.2× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)0 · sector 26
PAST (return on equity)0 · sector 24
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)14 · sector 19

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Keysight Technologies, Inc KEYS $347.32 $115.39 −67%
Garmin Ltd GRMN $284.67 $304.44 +7%
Teledyne Technologies Incorporated TDY $612.74 $674.01 +10%
Chroma ATE Inc 2360 2,295 TWD 618.78 TWD −73%
MKS Inc MKSI $260.37 $201.24 −23%
AVIC Chengdu Aircraft Company 302132 ¥59.95 ¥19.61 −67%
Fortive Corporation FTV $55.95 $34.86 −38%
Trimble Inc TRMB $59.30 $29.11 −51%
Cognex Corporation CGNX $58.97 $38.50 −35%
Wuhan Guide Infrared Co 002414 ¥12.23 ¥9.52 −22%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nynomic AG · Fair Value
€13.51 −74%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Nynomic AG Fair Value". https://www.fairvalue-calculator.com/stock/M7U

Frequently asked questions

Is Nynomic AG (M7U) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of €13.51 versus a price of €23.50, about −43% upside (overvalued).
What is the fair value of M7U?
Our model-based fair value for Nynomic AG is €13.51 (as of Sep 23, 2026), built from audited fundamentals. The current price: €23.50.
What is the quality score of M7U?
Nynomic AG has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nynomic AG (M7U)?
Our model-based price target is the fair value of €13.51 (as of Sep 23, 2026) from 13 valuation models. Cautious scenario €9.79, optimistic scenario €17.47. It is a calculation from audited fundamentals, not an analyst target.
What is the Nynomic AG stock forecast for 2026?
Our models put fair value at €13.51, about −43% upside versus a price of €23.50 (overvalued). Cautious scenario €9.79, optimistic scenario €17.47. The calculation is refreshed regularly with new filings.
What is the revenue of Nynomic AG (M7U)?
Nynomic AG reported trailing-twelve-month revenue of about €93.2M (latest available figure, as of Sep 23, 2026).
Does Nynomic AG pay a dividend?
Nynomic AG currently shows a dividend yield of about 0.68% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Nynomic AG (M7U)?
For today's price to be fair in a discounted-cash-flow model, Nynomic AG would have to grow free cash flow by +21.0 % per year for five years (discount rate 12.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.3 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of M7U use?
Our models discount Nynomic AG at 12.7 %: a base by market capitalisation (micro), damped by beta 1.07, country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nynomic AG that is +21.0 % per year a year over ten years, using the same discount rate (12.7 %) and the same formula as our fair value.
How much growth has Nynomic AG (M7U) delivered so far?
Over the past 5 years revenue at Nynomic AG grew +3.3 % a year. The price currently implies +21.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nynomic AG (M7U) growing?
The median revenue growth in the sector is +8.2 % a year. That is the yardstick for the growth priced into Nynomic AG (+21.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nynomic AG (M7U)?
The free-cash-flow yield on the price is 3.72 %: that much free cash flow Nynomic AG produces per unit of market value. When it exceeds the discount rate of our models (12.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nynomic AG (M7U)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nynomic AG it is €13.51 per share (as of Sep 23, 2026), against a price of €23.50. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Nynomic AG stock overvalued or undervalued in 2026?
As of Sep 23, 2026, M7U trades above its calculated fair value: price €23.50, fair value €13.51, a gap of about −43% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of M7U?
No. The price is what the market pays today (€23.50); the fair value is what the company's own numbers justify (€13.51). For Nynomic AG the two are €9.99 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nynomic AG worth?
The market values Nynomic AG at about €154M (market capitalisation, as of Sep 23, 2026). Per share that is €23.50; our models calculate a fair value of €13.51 per share.
What do the bullish and bearish scenarios say about M7U?
Our models span a range for Nynomic AG: cautious scenario €9.79, base €13.51, optimistic €17.47 per share (as of Sep 23, 2026, price €23.50). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nynomic AG (M7U)?
Balance-sheet figures for Nynomic AG (as of Sep 23, 2026): return on equity −0.3%, debt of 0.00 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is M7U from its 52-week high?
Nynomic AG trades at €23.50, about 6% below its 52-week high of €25.00 and 181% above the low of €8.36 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of €13.51 is for.
Which stocks are comparable to Nynomic AG?
From the same area (Technology) we also value Keysight Technologies, Inc, Garmin Ltd, Teledyne Technologies Incorporated, Chroma ATE Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nynomic AG stock attractive at the current price?
The data as of Sep 23, 2026: price €23.50, calculated fair value €13.51 (−43%), Quality Score 50/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of M7U calculated?
We run Nynomic AG through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €13.51, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Nynomic AG itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nynomic AG (M7U)?
The closing price on Sep 24, 2026 was €23.50. Our model-based fair value is €13.51, about −43% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nynomic AG right now?
The price sits above even our optimistic bull case (€17.47). The favourable scenario is already priced in. Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Nynomic AG

How large is the market capitalisation of Nynomic AG (M7U)?
The market capitalisation of Nynomic AG is €154M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nynomic AG (M7U)?
The price-to-sales ratio of Nynomic AG is 1.12 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nynomic AG (M7U)?
Earnings per share at Nynomic AG are €−0.1100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Nynomic AG (M7U)?
The dividend yield of Nynomic AG is 0.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Nynomic AG (M7U)?
The net margin of Nynomic AG is −0.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nynomic AG (M7U)?
The return on equity (ROE) of Nynomic AG is −0.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nynomic AG (M7U)?
On an EBIT basis the return on assets of Nynomic AG is 7.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nynomic AG (M7U)?
The operating margin of Nynomic AG is 7.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nynomic AG (M7U)?
Revenue at Nynomic AG is growing −11.6% versus a year earlier (3y avg −7.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Nynomic AG (M7U)?
Earnings per share at Nynomic AG are growing −1.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Nynomic AG (M7U) carry?
The net debt of Nynomic AG is €3.4M (fiscal year 2025, ≈ 0.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Nynomic AG in the live analysis

One click puts Nynomic AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.